1-5 of 5
David M. Markovitz
Close
Sort by
Journal Articles

Extracellular DEK Activates NRF2 Antioxidant Targets and Drives Expansion of Functional and ROS-Low Human Hematopoietic Stem Cells

James Ropa, Sarah Gutch, Lindsay Beasley, Paola Aguilar Neuville, Scott Cooper, Di Cao, Wouter van't Hof, Maureen Legendre, Mark Kaplan, David M Markovitz, Maegan L. Capitano
Journal: Blood
Blood (2022) 140 (Supplement 1): 8576–8577.
https://doi.org/10.1182/blood-2022-170089
Published: 2022
Journal Articles

Extracellular DEK Treatment Mimics Hypoxic Blockade of Extra Physiologic Oxygen Stress in Human and Mouse Hematopoietic Cells

James Ropa, Scott Cooper, Lindsay Beasley, David M Markovitz, Hal E. Broxmeyer, Maegan L. Capitano
Journal: Blood
Blood (2021) 138 (Supplement 1): 2152.
https://doi.org/10.1182/blood-2021-151171
Published: 2021
Journal Articles

CAR-NK Cells Targeting Sars-Cov-2 Glycosites As COVID-19 Treatment

Ilias Christodoulou, Ruyan Rahnama, Wesley J. Ravich, Jaesung Seo, Sergey Zolov, Andrew Marple, David M Markovitz, Challice L. Bonifant
Journal: Blood
Blood (2021) 138 (Supplement 1): 2803.
https://doi.org/10.1182/blood-2021-146865
Published: 2021
Journal Articles

DEK Regulates Hematopoietic Stem Engraftment and Progenitor Cell Proliferation

Hal E. Broxmeyer, PhD, Ferdinand Kappas, MD, Nirit Mor-Vaknin, PhD, MSc, Maureen Legendre, John Kinzfogl, Scott Cooper, BS, Giao Hangoc, DVM, David M. Markovitz, MD
Journal: Blood
Blood (2011) 118 (21): 1275.
https://doi.org/10.1182/blood.V118.21.1275.1275
Published: 2011
Journal Articles

Role of Human Endogenous Retroviruses in Lymphoma Pathogenesis and a Possible Biomarker of Disease

Scott D. Gitlin, MD, Rafael Contreras- Galindo, Mark H. Kaplan, David M. Markovitz
Journal: Blood
Blood (2008) 112 (11): 3751.
https://doi.org/10.1182/blood.V112.11.3751.3751
Published: 2008